It is well known that complement proteins are considered to be powerful proinflammatory molecules in the body [24], and recently, C3 was evidenced as a key player in the production and activation of ovarian cancer growth and progression [25]; however, there is still no evidence associated with CFB in oral tumorigenic processes. The gene discussed is VTN; the disease is ovarian carcinoma.